ORIGINAL RESEARCH
Accepted on 16 Jul 2025
Combined treatment with CDK4/6, CDK2, and CXCR1/2 inhibitors effectively halt the growth of BRAF wild-type melanoma tumors
doi 10.3389/fonc.2025.1609735
- 158 views
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Research Topics
- Innovative Drug Combinations for Enhanced Solid Tumor Treatment Efficacy
Innovative Drug Combinations for Enhanced Solid Tumor Treatment Efficacy
1,061
Total downloads
6,263
Total views and downloads
Articles
REVIEW
Accepted on 07 Jul 2025
SLFN11: A Pan-Cancer Biomarker for DNA-Targeted Drugs Sensitivity and Therapeutic Strategy Guidance
doi 10.3389/fonc.2025.1582738
- 136 views
ORIGINAL RESEARCH
Published on 04 Jun 2025
Aumolertinib plus bevacizumab for untreated advanced NSCLC with EGFR sensitive mutation
doi 10.3389/fonc.2025.1595812
- 967 views
ORIGINAL RESEARCH
Published on 16 May 2025
A trispecific antibody targeting EGFR/cMET/VEGF-A demonstrates multiple mechanisms of action to inhibit wild-type and mutant NSCLC animal models
doi 10.3389/fonc.2025.1533059
- 1,775 views
CASE REPORT
Published on 26 Feb 2025
Efficacy of anlotinib and chemotherapy combination as neoadjuvant therapy in the treatment of pulmonary artery intimal sarcoma: a case report
doi 10.3389/fonc.2025.1507281
- 684 views
SYSTEMATIC REVIEW
Published on 07 Jan 2025
Efficacy and safety of nivolumab plus ipilimumab in gastrointestinal cancers: a systematic review and meta-analysis
doi 10.3389/fonc.2024.1515992
- 1,002 views
